Our mission is to provide patients and physicians with NeuroScreen®, our accurate and affordable blood test for screening and monitoring asymptomatic Alzheimer’s disease.
Alzheimer’s disease is a neurodegenerative disease characterized by cognitive decline, functional impairment, and dementia. Recent studies have learned that changes in biomarkers can begin up to 20 years before a patient is symptomatic, but there has been no effective way to identify patients until now.
To meet that need, NeuroQuest developed NeuroScreen™, a novel blood-based diagnostic test for Alzheimer’s disease based on the specific response of the immune system. Its algorithm examines leukocytes to predict the presence and quantity of amyloid plaques in the brain, the pathological component of Alzheimer’s disease. Early detection of the disease allows patient-centric medical decisions to be made by physicians and was shown to enhance treatment efficiency.
Company Details
- Employees
- 10
- Founded
- 2008
- Address
- Charleston, South Carolina 29401, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.neuroquest-usa.com/
- Keywords
- Charleston.
- HQ
- Charleston, South Carolina
Neuroquest Ltd. Questions
Neuroquest Ltd.'s website is https://www.neuroquest-usa.com/
Neuroquest Ltd.'s LinkedIn profile is https://www.linkedin.com/company/neuroquest-ltd
Neuroquest Ltd. has
10 employees.
View email and phone details for 10
employees at Neuroquest Ltd..
Neuroquest Ltd.'s industry is
Biotechnology Research
Neuroquest Ltd.'s top competitors are
Ripple Two,
Heartbeat Tech Inc.,
Sensomedical Usa,
Southernside Brewing Co.,
Realize Ascent Labs, Llc,
Oncoblaze,
Pulmanage, Inc,
Volare Boats,
Bildit,
Vayuclear Llc.
Neuroquest Ltd.'s categories are Biotechnology Research
Neuroquest Ltd.'s founding year is 2008
